Glenn Heller

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Inflammatory Response

Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Lifetime data analysis

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Noura J Choudhury, W Victoria Lai, Alex Makhnin, Glenn Heller, Juliana Eng, Bob T Li, Isabel R Preeshagul, Fernando C Santini, Michael D Offin, Kenneth Ng, Paul K Paik, Christina Larsen, Michelle S Ginsberg, Yvonne Lau, Xinyuan Zhang, Marina K Baine, Natasha Rekhtman, Charles M Rudin
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Jeffrey L Jensen, Olivia Bobek, Irenaeus C C Chan, Brian C Miller, David W Hillman, Glenn Heller, Todd E Druley, Andrew J Armstrong, Michael J Morris, Matthew I Milowsky, Himisha Beltran, Kelly L Bolton, Catherine C Coombs
Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201). Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Noura J Choudhury, W Victoria Lai, Alex Makhnin, Glenn Heller, Juliana Eng, Bob T Li, Isabel R Preeshagul, Fernando C Santini, Michael D Offin, Kenneth Ng, Paul K Paik, Christina Larsen, Michelle S Ginsberg, Yvonne Lau, Xinyuan Zhang, Marina K Baine, Natasha Rekhtman, Charles M Rudin
A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Noura J Choudhury, W Victoria Lai, Alex Makhnin, Glenn Heller, Juliana Eng, Bob T Li, Isabel R Preeshagul, Fernando C Santini, Michael D Offin, Kenneth Ng, Paul K Paik, Christina Larsen, Michelle S Ginsberg, Yvonne Lau, Xinyuan Zhang, Marina K Baine, Natasha Rekhtman, Charles M Rudin
A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Manpreet Bariana, Elena Cassella, Janice Rateshwar, Samedy Ouk, Hsiou-Chi Liou, Claudia Heller, Iriana Colorado, Rena Feinman, Ali Makhdoom, David S Siegel, Glenn Heller, Andrea Tuckett, Patrizia Mondello, Johannes L Zakrzewski
Inhibition of NF-κB DNA Binding Suppresses Myeloma Growth via Intracellular Redox and Tumor Microenvironment Modulation. Molecular cancer therapeutics 21 (12) (2022)
Glenn Heller
The added value of new covariates to the brier score in cox survival models. Lifetime data analysis 27 (1) (2020)